NPI: 1669567319 · ATHENS, TN 37303 · General Acute Care Hospital · NPI assigned 10/04/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 10/04/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 55,509 | $1.99M |
| 2019 | 58,186 | $2.06M |
| 2020 | 48,460 | $1.53M |
| 2021 | 49,539 | $1.70M |
| 2022 | 52,488 | $1.82M |
| 2023 | 51,231 | $1.78M |
| 2024 | 31,184 | $1.34M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 41,608 | 35,926 | $3.17M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 31,883 | 25,675 | $2.81M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 12,787 | 10,794 | $836K |
| 96361 | Intravenous infusion, hydration; each additional hour | 7,640 | 6,263 | $801K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,302 | 4,157 | $568K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 13,006 | 10,018 | $447K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6,904 | 6,236 | $426K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5,161 | 4,651 | $309K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 9,639 | 8,238 | $260K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 40,058 | 29,988 | $232K |
| 96375 | Therapeutic injection; each additional sequential IV push | 7,354 | 6,012 | $224K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,781 | 2,279 | $219K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,147 | 2,972 | $158K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,101 | 2,438 | $147K |
| 80053 | Comprehensive metabolic panel | 23,730 | 18,197 | $117K |
| 0240U | 1,489 | 1,274 | $113K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2,581 | 903 | $113K |
| 84484 | 7,723 | 5,418 | $110K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,129 | 1,679 | $109K |
| 59025 | Fetal non-stress test | 1,289 | 992 | $104K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6,374 | 5,248 | $102K |
| 71045 | Radiologic examination, chest; single view | 8,285 | 6,458 | $89K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6,808 | 5,285 | $60K |
| G0378 | Hospital observation service, per hour | 410 | 312 | $50K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3,177 | 2,722 | $50K |
| 71046 | Radiologic examination, chest; 2 views | 2,717 | 2,310 | $49K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,507 | 2,977 | $46K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 445 | 351 | $45K |
| 87430 | 3,536 | 3,283 | $40K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 346 | 326 | $39K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 170 | 141 | $35K |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,221 | 7,189 | $35K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 353 | 310 | $35K |
| 81001 | 23,874 | 19,322 | $33K | |
| 83690 | 5,197 | 4,137 | $33K | |
| 95811 | 147 | 116 | $22K | |
| 81025 | 3,792 | 3,284 | $18K | |
| 87081 | 2,372 | 2,207 | $17K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 728 | 627 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,170 | 1,696 | $15K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 215 | 76 | $12K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 172 | 135 | $9K |
| 97597 | 237 | 97 | $9K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 277 | 67 | $8K |
| 36415 | Collection of venous blood by venipuncture | 3,490 | 2,454 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 486 | 391 | $6K |
| 85018 | 815 | 798 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,362 | 1,143 | $5K |
| 36416 | 722 | 683 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 123 | 104 | $4K |
| 83880 | 407 | 307 | $4K | |
| 83655 | 102 | 101 | $4K | |
| 83605 | 540 | 375 | $3K | |
| 82150 | 592 | 455 | $3K | |
| 96367 | 27 | 12 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,053 | 2,618 | $3K |
| 87040 | 280 | 165 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,262 | 1,140 | $2K |
| 85730 | 652 | 502 | $2K | |
| 87186 | 224 | 193 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 7,590 | 6,271 | $2K |
| 87807 | 111 | 106 | $1K | |
| 85610 | 711 | 553 | $1K | |
| 82728 | 248 | 208 | $1K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 26 | 12 | $1K |
| 83550 | 273 | 230 | $964.29 | |
| 87077 | 224 | 193 | $916.82 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,666 | 4,020 | $862.47 |
| 82077 | 27 | 24 | $717.55 | |
| 83540 | 273 | 230 | $685.48 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 15 | 14 | $660.66 |
| 82550 | 206 | 153 | $643.35 | |
| 83735 | 131 | 87 | $603.17 | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 77 | 15 | $584.32 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 88 | 38 | $570.54 |
| 84702 | 31 | 26 | $555.84 | |
| 85379 | 35 | 25 | $380.95 | |
| 83615 | 314 | 259 | $375.95 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 347 | 315 | $327.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 28 | 24 | $325.88 |
| 86140 | 87 | 82 | $316.81 | |
| 99239 | Hospital discharge day management, more than 30 minutes | 27 | 17 | $296.42 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 26 | 15 | $294.98 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 234 | 214 | $255.12 |
| 85652 | 100 | 94 | $175.94 | |
| 82962 | 83 | 28 | $161.22 | |
| 80061 | Lipid panel | 45 | 38 | $144.22 |
| 87210 | 39 | 30 | $135.34 | |
| 73630 | 14 | 13 | $130.71 | |
| C9113 | Injection, pantoprazole sodium, per vial | 13 | 12 | $121.76 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 153 | 126 | $104.59 |
| 82553 | 67 | 50 | $100.26 | |
| 82607 | 62 | 57 | $98.50 | |
| 82805 | 14 | 12 | $91.01 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 70 | 62 | $73.78 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 97 | 87 | $73.11 |
| 82746 | 47 | 44 | $50.85 | |
| 85027 | 16 | 14 | $14.84 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 225 | 159 | $12.09 |
| 84439 | 16 | 12 | $10.38 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 88 | 60 | $8.96 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 184 | 151 | $7.56 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 12 | 12 | $5.60 |
| A9270 | Non-covered item or service | 197 | 185 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 172 | 119 | $0.00 |
| 87070 | 47 | 38 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 25 | 14 | $0.00 |
| 85014 | 37 | 25 | $0.00 |